Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
about
Polycomb group expression signatures in the malignant progression of gliomas.dBRWD3 Regulates Tissue Overgrowth and Ectopic Gene Expression Caused by Polycomb Group Mutations.RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy.Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapyMetastatic biomarkers in synovial sarcoma.Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP.Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.Polycomb Repressor Complex 2 in Genomic Instability and CancerPolycomb group proteins: Novel molecules associated with ultraviolet A-induced photoaging of human skin.Regulation of cancer epigenomes with a histone-binding synthetic transcription factor.Demethylated HSATII DNA and HSATII RNA Foci Sequester PRC1 and MeCP2 into Cancer-Specific Nuclear Bodies.Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells.Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon.Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma.The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells
P2860
Q33599449-76F7DD03-5EC5-4DCC-9C28-2D32302DE56EQ36121350-6610BBF0-D7E7-4B26-AE9D-BCEC1EDDD1B4Q36522589-57920BED-EF9C-4338-B69B-AC95D5A193D8Q37097416-F1C8FD32-3822-44F8-A358-073434587FD6Q37630943-FB2E740A-70B2-4C5F-A71C-93C8F41465EDQ37706349-7DEB5332-248D-4630-B007-A080A3E3BD7EQ38713758-3D8ED1B0-4621-493A-9C97-FEA1FE32CB3CQ41573279-1AFCDF6D-7B9E-425B-9F74-D611C4F34F6BQ41672054-85BB1D58-BD6D-4989-8D9D-9E80B264FE87Q41734326-845D97BC-AD13-48DE-AB35-45C443B9C368Q41813113-31EC0653-F30B-48E9-821C-6F05E78FE00CQ42266789-307203F2-575C-42B9-87BF-959DE62653B2Q42367900-F0EBEF80-79BC-4B5C-84CB-86B1A3787BD6Q52691495-B5C4DAB4-16C3-43D8-A5C9-7E630CE4FB3EQ54946976-9B91B771-FAC8-45F0-A8F0-F79AACB064DBQ55410595-BC0DAB89-9018-44A2-B8FD-A59B6E9621C0Q57826206-A1BCFAC8-F8C3-40CF-AB55-A4DF916B0BA9
P2860
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@ast
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@en
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@nl
type
label
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@ast
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@en
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@nl
prefLabel
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@ast
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@en
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@nl
P2093
P2860
P3181
P356
P1476
Polycomb Group (PcG) Proteins ...... s and Therapeutic Implications
@en
P2093
Jianwei Zhou
Ruiwen Zhang
Sukesh Voruganti
P2860
P304
P3181
P356
10.1002/MED.21358
P407
P577
2015-07-30T00:00:00Z